[at noodls] – SOUTH SAN FRANCISCO, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at two upcoming … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboardSee who Sunesis is hiring next, click here to view […]
[at noodls] – SOUTH SAN FRANCISCO, Calif., Feb. 6, 2013 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Eric Bjerkholt, Executive Vice President, Corporate Development and Finance … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboardSee who Sunesis is hiring next, click here to view […]
[at noodls] – VALOR Enrollment Reaches 500 Patients; Enrollment Doubles in LI-1 Trial SOUTH SAN FRANCISCO, Calif., Jan. 10, 2013 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboardSee who Sunesis is hiring next, click here to view […]
[at noodls] – SOUTH SAN FRANCISCO, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboardSee who Sunesis is hiring next, click here to view […]
[at noodls] – SOUTH SAN FRANCISCO, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Sunesis to Host Conference Call Today at 11:00AM Eastern Time SOUTH SAN FRANCISCO, Calif., Nov. 8, 2012 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SOUTH SAN FRANCISCO, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Sunesis to Host Conference Call on November 8th to Discuss Third Quarter Financial Results and Recent Highlights SOUTH SAN FRANCISCO, Calif., Nov. 1, 2012 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David MoskowitzSunesis Pharmaceuticals (NASDAQ:SNSS) is getting the benefit of a price target increase this morning; Roth Capital raised its price target on the stock from $7.00 to $12.00, after the … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David MoskowitzSunesis Pharmaceuticals (NASDAQ:SNSS) has had a great year thus far, up 350% since January, and importantly, the smart money continues to flock to the name. The key driver is the company’s … moreView todays social media effects on SNSSView the latest stocks trending across Twitter. Click to view dashboard […]
